跳至主要内容
临床试验/NL-OMON51461
NL-OMON51461已完成不适用

A multi-center, real-world exploratory cohort study to evaluate cough frequency, severity, and impact on quality of life in patients with non-idiopathic pulmonary fibrosis interstitial lung disease - Evaluating cough and impact on quality of life in pulmonary fibrosis

Boehringer Ingelheim0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Provision of signed informed consent in writing prior to study data collection
  • - Subject aged 18 years or over
  • - Subject diagnosed with non-IPF fibrosing ILD

排除标准

  • - Cough due to etiology other than ILD (e.g., allergic rhinitis,
  • Gastroesophageal Reflux Disease (GERD))
  • - Other respiratory disorders including, but not limited to, a current
  • diagnosis of any obstructive disease including chronic obstructive pulmonary
  • disease (COPD) and asthma, active tuberculosis, lung cancer in treatment or in
  • medical history, sleep apnea, known alpha-1 antitrypsin deficiency, cor
  • pulmonale, clinically significant pulmonary hypertension, clinically
  • significant bronchiectasis, or other active pulmonary diseases
  • - Respiratory infection or use of antibiotics for respiratory cause within 4
  • weeks prior to study entry
  • - Initiation or change in dose or type of anti-tussive medication,
  • angiotensin-converting enzyme (ACE) inhibitors, or corticosteroids in the 4
  • weeks prior to study entry
  • - Subject with airflow obstruction (forced expiratory volume in one second
  • (FEV1)/FVC<0.7) or known significant spirometry response to bronchodilator

研究者

相似试验

尚未招募
4 期
A multicenter, prospective, real-world study on the treatment of stable chronic obstructive pulmonary disease with Guben Kechuan granuleschronic obstructive pulmonary disease
ITMCTR2024000226Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital
招募中
不适用
A multicenter seamless prospective cohort study and single-arm confirmatory clinical trial for the venous thromboembolism in gynecological cancer patients.gynecological cancer
JPRN-UMIN000026886GOTIC1,000
尚未招募
不适用
A multicenter, prospective, open, cohort study on the efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of chronic kidney disease stage 3-4chronic kidney disease stage 3-4
ITMCTR2200006493the First Affiliated Hospital of Anhui University of Chinese Medicine
进行中(未招募)
不适用
A prospective, randomized, open, multi-centre study to assess safety of PURETHAL Grasses given with a rush induction schedule to patients with allergic rhinoconjunctivitis. - PURETHAL Grasses Rush studyAllergic (IgE-mediated) rhinitis/rhinoconjunctivitis due to sensitization to grass pollenMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001726Term: Allergic rhinitis due to pollenMedDRA version: 12.0Level: LLTClassification code 10053741Term: Allergenic desensitization procedure
EUCTR2009-015012-18-DEHAL Allergy BV
进行中(未招募)
不适用
PURETHAL Birch Rush study.PURETHAL is indicated for specific immunotherapy (desensitisation) of IgE-mediated, inhaled allergy with symptoms of allergic rhinitis, allergic conjunctivitis and allergic bronchial asthma with an allergic background.MedDRA version: 16.0Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855
EUCTR2013-000086-36-PLHAL Allergy B.V.120